Sana Biotechnology Inc [NASDAQ: SANA] stock went on an upward path that rose over 3.18% on Wednesday, amounting to a one-week price increase of more than 0.69%.
Over the last 12 months, SANA stock rose by 79.14%. The one-year Sana Biotechnology Inc stock forecast points to a potential upside of 64.39. The average equity rating for SANA stock is currently 1.29, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $658.62 million, with 225.46 million shares outstanding and 125.44 million shares in the current float. Compared to the average trading volume of 4.11M shares, SANA stock reached a trading volume of 7626942 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Sana Biotechnology Inc [SANA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SANA shares is $8.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SANA stock is a recommendation set at 1.29. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citizens JMP have made an estimate for Sana Biotechnology Inc shares, keeping their opinion on the stock as Mkt Outperform, with their previous recommendation back on March 18, 2025. While these analysts kept the previous recommendation, Jefferies raised their target price to Buy. The new note on the price target was released on March 14, 2025, representing the official price target for Sana Biotechnology Inc stock.
The Price to Book ratio for the last quarter was 3.15, with the Price to Cash per share for the same quarter was set at 0.48.
SANA Stock Performance Analysis:
Sana Biotechnology Inc [SANA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.69. With this latest performance, SANA shares gained by 32.73% in over the last four-week period, additionally plugging by 81.37% over the last 6 months – not to mention a rise of 79.14% in the past year of trading.
Insight into Sana Biotechnology Inc Fundamentals:
Return on Equity for this stock declined to -37.04%, with Return on Assets sitting at -37.04%.
SANA Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SANA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Sana Biotechnology Inc go to 14.07%.
Sana Biotechnology Inc [SANA] Institutonal Ownership Details
The top three institutional holders of SANA stocks are: FMR LLC with ownership of 27.17 million shares, which is approximately 11.5894%. FLAGSHIP PIONEERING INC., holding 25.0 million shares of the stock with an approximate value of $$136.51 million in SANA stocks shares; and FLAGSHIP PIONEERING INC., currently with $$70.32 million in SANA stock with ownership which is approximately 5.4934%.
